| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SAREPTA THERAPEUTICS INC | 1,369,909 | 84,126,000 | 14.76% | ||
| 2 | BIOMARIN | 419,712 | 38,832,000 | 6.81% | ||
| 3 | Lion Biotechnologies | 4,257,347 | 35,038,000 | 6.15% | ||
| 4 | TESARO INC | 277,703 | 27,837,000 | 4.88% | ||
| 5 | AMICUS THERAPEUTICS INC | 3,689,857 | 27,305,000 | 4.79% | ||
| 6 | DERMIRA INC | 805,926 | 27,256,000 | 4.78% | ||
| 7 | AGENUS INC | 3,715,938 | 26,680,000 | 4.68% | ||
| 8 | ACADIA PHARMACEUTICALS INC COM | 792,499 | 25,209,000 | 4.42% | ||
| 9 | NEUROCRINE BIOSCIE COM USD0.001 | 490,582 | 24,843,000 | 4.36% | ||
| 10 | IMMUNOMEDICS INC | 7,344,177 | 23,869,000 | 4.19% | ||
| 11 | BRISTOL MYERS SQUIBB CO | 399,875 | 21,561,000 | 3.78% | ||
| 12 | GLOBAL BLOOD THERAPEUTICS IN COM | 869,263 | 20,037,000 | 3.52% | ||
| 13 | AERIE PHARMACEUTICALS INC | 500,000 | 18,870,000 | 3.31% | ||
| 14 | GW PHARMACEUTICALS PLC | 133,600 | 17,733,000 | 3.11% | ||
| 15 | VANDA PHARMACEUTICALS INC COM | 827,693 | 13,773,000 | 2.42% | ||
| 16 | NEURODERM LTD | 686,303 | 12,690,000 | 2.23% | ||
| 17 | TELIGENT INC NEW | 1,637,819 | 12,447,000 | 2.18% | ||
| 18 | SORRENTO THERAPEUTICS INC COM NEW | 1,531,273 | 11,852,000 | 2.08% | ||
| 19 | MIRATI THERAPEUTICS INC COM | 1,488,487 | 9,839,000 | 1.73% | ||
| 20 | CASCADIAN THERAPEUTICS INC | 5,611,323 | 9,203,000 | 1.61% | ||
| 21 | AKEBIA THERAPEUTICS INC | 944,579 | 8,548,000 | 1.50% | ||
| 22 | AGIOS PHARMACEUTICALS INC | 150,000 | 7,923,000 | 1.39% | ||
| 23 | SEATTLE GENETICS INC | 141,500 | 7,642,000 | 1.34% | ||
| 24 | VERACYTE INC | 918,556 | 6,990,000 | 1.23% | ||
| 25 | BIOCRYST PHARMACEUTICALS | 1,379,402 | 6,083,000 | 1.07% | ||
| 26 | SAREPTA THERAPEUTICS INC | 190,000 | 6,033,000 | 1.06% | Call | |
| 27 | ALIMERA SCIENCES INC | 3,575,000 | 5,327,000 | 0.93% | ||
| 28 | TRILLIUM THERAPEUTICS INC | 316,020 | 4,671,000 | 0.82% | ||
| 29 | CORVUS PHARMACEUTICALS INC COM | 268,369 | 4,415,000 | 0.77% | ||
| 30 | FORTRESS BIOTECH INC | 1,356,636 | 4,029,000 | 0.71% | ||
| 31 | PROTEOSTASIS THERAPEUTICS IN | 179,565 | 2,799,000 | 0.49% | ||
| 32 | INNOCOLL HLDGS PLC | 468,148 | 2,720,000 | 0.48% | ||
| 33 | PERNIX THERAPEUTICS HOLDINGS INC | 7,000,000 | 2,050,000 | 0.36% | PRN | |
| 34 | ASSEMBLY BIOSCIENCES INC | 268,119 | 1,933,000 | 0.34% | ||
| 35 | ONCOBIOLOGICS INC | 450,872 | 1,916,000 | 0.34% | ||
| 36 | CELLECTIS S A | 58,671 | 1,413,000 | 0.25% | ||
| 37 | VERSARTIS INC COM | 95,742 | 1,173,000 | 0.21% | ||
| 38 | ONCOMED PHARMACEUTICALS INC | 85,000 | 972,000 | 0.17% | ||
| 39 | Ascendis Pharma | 45,203 | 909,000 | 0.16% | ||
| 40 | AGENUS INC | 1,000,000 | 800,000 | 0.14% | Call | |
| 41 | CEMPRA INC | 30,000 | 726,000 | 0.13% | ||
| 42 | VERICEL CORP | 215,744 | 604,000 | 0.11% | ||
| 43 | Nantkwest Inc | 72,412 | 563,000 | 0.10% | ||
| 44 | Dicerna Pharmaceuticals | 46,082 | 271,000 | 0.05% | ||
| 45 | ONCOBIOLOGICS INC - WARRANT B | 233,333 | 233,000 | 0.04% | ||
| 46 | ONCOBIOLOGICS INC - WARRANT A | 233,333 | 112,000 | 0.02% | ||
| 47 | IMMUNOMEDICS INC | 300,800 | 53,000 | 0.01% | Call | |
| 48 | SAREPTA THERAPEUTICS INC | 75,600 | 2,000 | 0.00% | Put |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-134109, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
